Argenx Se (ARGX) Interest & Investment Income (2016 - 2026)
Argenx Se's (ARGX) quarterly Interest & Investment Income came in at $48.0 million in Q2 2026, up 25.0% on a YoY basis from $38.4 million in Q2 2025, and up 9.09% quarter-over-quarter from $44.0 million in Q1 2026.
Powered by 
Analysis
Argenx Se (ARGX) Interest & Investment Income (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Interest & Investment Income for 11 consecutive years, with $48.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 25.0% year-over-year to $48.0 million; the trailing twelve-month figure through Jun 2026 stood at $179.6 million (up 15.79% YoY), and the FY2025 full-year result was $163.1 million, up 3.54% from the prior year.
- Interest & Investment Income rose to $48.0 million in Q2 2026 per ARGX's latest filing, from $44.0 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $48.0 million in Q2 2026 and bottomed at $821000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $30.4 million across 5 years, with a median of $38.6 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income jumped 1920.46% in 2023, then decreased 4.87% in 2025.
- Over 5 years, Interest & Investment Income stood at $13.9 million in 2022, then surged by 189.46% to $40.3 million in 2023, then fell by 3.01% to $39.1 million in 2024, then increased by 14.78% to $44.9 million in 2025, then increased by 6.97% to $48.0 million in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $48.0 million, $44.0 million, and $44.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | - |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 120.60 Mn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 48.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 48.00 Mn |
| Mar 31, 2026 | 44.00 Mn |
| Dec 31, 2025 | 44.87 Mn |
| Sep 30, 2025 | 42.70 Mn |
| Jun 30, 2025 | 38.40 Mn |
| Mar 31, 2025 | 37.00 Mn |
| Dec 31, 2024 | 39.10 Mn |
| Sep 30, 2024 | 40.59 Mn |
| Jun 30, 2024 | 38.93 Mn |
| Mar 31, 2024 | 38.90 Mn |
| Dec 31, 2023 | 40.31 Mn |
| Sep 30, 2023 | 30.05 Mn |
| Jun 30, 2023 | 20.44 Mn |
| Mar 31, 2023 | 16.59 Mn |
| Dec 31, 2022 | 13.93 Mn |
| Sep 30, 2022 | 8.01 Mn |
| Jun 30, 2022 | 4.91 Mn |
| Mar 31, 2022 | 821,000.00 |
| Dec 31, 2021 | 1.20 Mn |
| Sep 30, 2021 | 805,000.00 |
API Access
Argenx Se Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();